Guardian Pharmacy Services Inc Cla (GRDN) financials

NYSE · Health Care

$40.69 +0.59% Close Oct 30, 2026 Live

Guardian Pharmacy Services Inc Cla revenue and earnings by year

Guardian Pharmacy Services Inc Cla's revenue was $1.45 billion in the fiscal year to December 31, 2025, up 17.9% from the year before. Net income was $49.2 million, 3.4% of revenue. Since the fiscal year to December 31, 2022, revenue has grown 16.8% a year on average.

RevenueNet income
$0$500M$1.00B$1.50B
2022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 4 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022
Revenue1.451.231.050.91
Revenue growth17.9%17.4%15.1%—
Gross profit0.290.240.210.19
Gross margin20.2%19.9%19.9%20.4%
Operating income0.07-0.060.040.05
Operating margin5.1%-5.1%3.9%5.7%
Net income0.05-0.110.000.04
Net margin3.4%-9.0%0.0%3.9%
Free cash flow0.080.040.060.03

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open GRDN in Markets.

See also: GRDN valuation and P/E history · GRDN returns

No forecast, no recommendation. This page describes Guardian Pharmacy Services Inc Cla from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.